SCHEMBL30890666

SCHEMBL30890666

CCCCOC(=O)N(C)[C@@H](CC1CC1)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 1/20 0.38
ITGA2B P08514 1/20 0.38
CHRNB2 P17787 2/20 0.36
CHRNB4 P30926 2/20 0.36
CHRNA3 P32297 2/20 0.36
CHRNA4 P43681 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 1/20 0.35
ATM Q13315 2/20 0.34
HCAR2 Q8TDS4 1/20 0.34
TSHR P16473 3/20 0.33
L3MBTL1 Q9Y468 3/20 0.33
TDP1 Q9NUW8 2/20 0.33
PTGIR P43119 1/20 0.33
PTGES O14684 1/20 0.33
ALOX5 P09917 1/20 0.33
PPARG P37231 1/20 0.33
HPGD P15428 2/20 0.33
CYP3A4 P08684 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30890639 1.00 ITGB3 (0.38) ITGB3ITGA2BCHRNB2CHRNB4CHRNA3
SCHEMBL10606737 0.93 CTSK (0.39) ITGB3ITGA2BCHRNB2CHRNB4CHRNA3
SCHEMBL5077756 0.82 ALDH1A1 (0.42) ALDH1A1MAPTATMHCAR2TSHR
SCHEMBL30890682 0.80 CTSK (0.38) ITGB3ITGA2B
SCHEMBL8591963 0.79 ALDH1A1 (0.38) CHRNB2CHRNB4CHRNA3CHRNA4ALDH1A1
SCHEMBL7375873 0.78 ALDH1A1 (0.39) CHRNB2CHRNB4CHRNA3CHRNA4ALDH1A1
SCHEMBL2966900 0.75 TSHR (0.44) ALDH1A1MAPTATMHCAR2TSHR
SCHEMBL2966906 0.75 TSHR (0.44) ALDH1A1MAPTATMHCAR2TSHR
SCHEMBL15555377 0.75 ALDH1A1 (0.36) ALDH1A1PTGESALOX5PPARG
SCHEMBL25183012 0.75 CTSS (0.40) ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 WO disclosed